Advancing Colorectal Cancer Care

These programs are intended for healthcare professionals only and are supported by an independent educational grant from the Healthcare business of Merck KGaA, Darmstadt, Germany.

Colorectal cancer is one of the most common cancers diagnosed in both men and women, making up to date insights on the latest research and management strategies essential. Advancing Colorectal Cancer Care captures expert perspectives on the changing treatment landscape, exploring new ideas on anti-EGFR inhibitors, the role of tumor sidedness, and more.

Sponsored by Merck KGaA, Darmstadt, Germany

GBPMLR/NONO/1019/0043c

Episodes 0-0 of 0

    Register

    We’re glad to see you’re enjoying Crohn's Colitis Professional…
    but how about a more personalized experience?

    Register for free